GelrinC

Regentis Wins European Approval for New GelrinC Process

HERZLIYA, Israel, July 15, 2026 Regentis Biomaterials announced that it has received approval from the European Notified Body for...

By cGxPwire Editor
July 18, 2026

MedTech

Regentis Develops Solvent-Free GelrinC Process Boost

HERZLIYA, Israel, March 17, 2026 Regentis Biomaterials Ltd. has announced a breakthrough solvent-free manufacturing process for its lead regenerative...

By cGxPwire Editor
March 18, 2026

.Clinical

Regentis Expands Phase III GelrinC Trial Across U.S. Sites

HERZLIYA, Israel, January 29, 2026 — Regentis Biomaterials Ltd. announced a significant expansion of its U.S. clinical site network...

By cGxPwire Editor
January 30, 2026

MedTech

Regentis IPO Fuels Advancement of GelrinC Regenerative MedTech

HERZLIYA, ISRAEL — December 5, 2025 — Regentis Biomaterials Ltd., a regenerative medicine MedTech company developing innovative tissue-repair solutions,...